middle.news
How EZZ’s US Launch and $21M Southeast Asia Deal Could Transform Its Growth
8:36am on Tuesday 29th of July, 2025 AEST
•
Life Sciences
Read Story
How EZZ’s US Launch and $21M Southeast Asia Deal Could Transform Its Growth
8:36am on Tuesday 29th of July, 2025 AEST
Key Points
Successful US market entry with EZZDAY brand and FDA-registered products
Secured $21 million three-year distribution deal in Southeast Asia with ROFA Enterprises
Expanded Australian pharmacy footprint via partnership with Direct Chemist Outlet
Launched new EZZ Liquid Calcium Soft Gel product and initiated bone health research with University of Sydney
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Ezz Life Science Holdings (ASX:EZZ)
OPEN ARTICLE